The observed BVMD phenotype of most clinically affected individuals apparently carrying heterozygous null mutations in BEST1 [22,23] probably correspond to compound heterozygotes who carry a missense mutation on the counter allele overlooked during the first genomic screening. Here, BEST1 is linked to Best vitelliform macular dystrophy.